MOONLAKE IMMUNOTHERAPEUTICS
Ticker : MLTX
SEC Filings
Current Reports
Proxy Statements
DEFA14A
2024-04-24
Beneficial Ownership Report
13G/A
2024-02-15
Subsidiaries